StudyFinder

OL Clinical Efficacy of Different Dosing Regimens of Efgartigimod IV Generalized MG (ADAPT NXT)

Status: OPEN TO ACCRUAL

I'm interested

Age:

Healthy Volunteers:

Interventions:

drug: Argx-113

Conditions:

Diseases of Nervous System and Sense Organs (320-389)

Contact(s): Wilkins, Bridget - bridget.wilkins@vcuhealth.org

Principal Investigator: Gwathmey, Kelly

Phase: III

IRB Number: HM20023221

System ID: NCT04980495

Back